期刊文献+

瞬时弹性成像系统在非酒精性脂肪性肝病中的诊断价值及其与中医分型的关系 被引量:4

The diagnostic value of fibroscan in nonalcoholic fatty liver disease and relationship with TCM differentiation
下载PDF
导出
摘要 目的:探讨瞬时弹性成像系统(Fibroscan)在非酒精性脂肪性肝病(NAFLD)中的诊断价值及其与中医分型的关系。方法:选择通过CT确诊的NAFLD的患者共64例,另外设健康对照50例,采用Fibroscan、CT肝/脾比值进行诊断比较,探讨Fibroscan在非酒精性脂肪性肝病中的诊断价值及其与中医分型的关系。结果:Fibroscan在诊断获得了最高的诊断效能,其灵敏度81.25%、特异性85.29%、阳性预测值91.22%、阴性预测值70.73%、约登指数0.66、ROC曲线下面积为0.78,并证明中医虚证患者Fibroscan的检测值大于实证患者[(269.32±33.98)vs(228.44±31.05),t=4.093,P=0.031]。结论:Fibroscan在NAFLD中的诊断效能较好,是定量诊断脂肪肝的可靠技术,与目前公认的CT诊断技术具有可比性,且中医虚实证型的Fibroscan检测值差异有显著性意义。 Objective:To investigate the diagnostic value of fibroscan in nonalcoholic fatty liver disease and relationship with TCM differentiation.Methods:sixty four cases with nonalcoholic fatty liver disease diagnosed by CT and 50 cases of healthy volunteers,as the control group were all selected.Fibroscan,CT and liver/spleen ratio were used for diagnosis and comparison.Results;FibroScan has the highest diagnostic efficiency in the diagnosis,the sensitivity was 81.25%,specificity 85.29%,positive predictive value 91.22%,negative predictive value 70.73%,Youden index 0.66 and the area under the ROC curve was 0.78.At the same time,the detection value of Fibroscan in patients with deficiency syndrome is greater than excess syndrome(269.32 ±33.98 vs 228.44 ±31.05,t = 4.093,P =0.031) Conclusion.- Fibroscan had better diagnostic efficiency in NAFLD than CT,which provides new ideas for clinical diagnosis on NAFLD.
出处 《中西医结合肝病杂志》 CAS 2016年第2期79-80,114,共3页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
关键词 FIBROSCAN 中医证型 非酒精性脂肪性肝病 诊断价值 Fibroscan traditional Chinese medicine non-alcoholic fatty liver disease
  • 相关文献

参考文献4

二级参考文献54

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1511
  • 2贾继东.酒精性和非酒精性脂肪性肝病的诊疗现状[J].肝脏,2006,11(1):55-56. 被引量:10
  • 3咸红.脂肪肝的药物治疗[J].安徽医药,2006,10(6):466-468. 被引量:5
  • 4Clark J M, Brancati F, Diehl A M. Nonalcoholic fatty liver disease [J]. Gastroenterology, 2002, 122 (6) : 1649 - 1657.
  • 5Augulo P, Lindor K D. Treatment of nonalcoholic fatty liver: present and emerging therapies [J]. Semin Liver Dis, 2001, 21 ( 1 ) :81-88.
  • 6Laaksonen D E, Nuutinen J, Lahtinen T, et al. Changes in abdominal subcutaneous fat water content with rap id weight loss and long term weightmaintenance in abdominally obese men and women[ J]. Int J Obes Relat Metab Disord, 2003, 27(6): 677-683.
  • 7Torjesen P A, Birkeland K I, Anderssen S A, et al. Lifestyle changes may reverse development of the insulin resistance syndrome [ J]. Diabetes Care, 1997, 20 ( 1 ) : 26-31.
  • 8Moschen A R, Tilg H. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease [ J ]. CUIT Opin Clan Nutr Metab Care, 2008, 11(5) :620-625.
  • 9Couillard C, Despres J P, Lamarche B, et al. Effect of endurance exercise training on plasa HDL cholesterol levels depend on levels of triglycerides: Evidence from men of the health, risk factors, exercise training and genetics (HERITAGE) family study [J].Arterioscler Thromb Vasc Biol, 2001, 21 (7) :1226-1232.
  • 10Ziol M,Handra-Luca A,Kettaneh A,Christidis C,Mal F,Ka- zemi F,de Lédinghen V,Marcellin P,Dhumeaux D,Trinchet JC,Beaugrand M.Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepa- titis C. Hepatology . 2005

共引文献111

同被引文献42

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部